Practice Point®: Hematology
von Practice Point Communications
Episode 51 - Podcast: What I'd Do Differently Tomorrow - Part 5 of…
Über diesen Podcast
Tune in to our hematology podcasts, where experts in the field of blood diseases unravel the complexities of hematology. Each episode covers the latest breakthroughs in the diagnosis, treatment, and management of hematologic conditions like leukemia, hemophilia, multiple myeloma and more. With in-depth discussions from leading hematologists, and insights from real-world cases, this podcast series provides healthcare professionals with the knowledge needed to navigate the world of blood disorders. Stay informed about cutting-edge research and hear inspiring stories of innovation in hematologic care.
Folgen
Die neuesten 20 von 51 Folgen
- Episode 51 - Podcast: What I'd Do Differently Tomorrow - Part 5 of RRMM Podcasts: Practical Insights for the First Relapse · 7 Min. · Folge 51Managing relapsed/refractory multiple myeloma (RRMM), particularly at first relapse, requires timely, evidence-based decisions in an increasingly complex treatment landscape. As…
- Episode 50 - Podcast: From Knowing to Doing: Overcoming Real-World Barriers - Part 4 of RRMM Podcasts: Practical Insights for the First Relapse · 8 Min. · Folge 50Managing relapsed/refractory multiple myeloma (RRMM), particularly at first relapse, requires timely, evidence-based decisions in an increasingly complex treatment landscape. As…
- Episode 49 - Podcast: Bispecific Antibodies Across Targets: Practical Integration in RRMM - Part 3 of RRMM Podcasts: Practical Insights for the First Relapse · 14 Min. · Folge 49Managing relapsed/refractory multiple myeloma (RRMM), particularly at first relapse, requires timely, evidence-based decisions in an increasingly complex treatment landscape. As…
- Episode 48 - Podcast: Making Sense of Immunotherapy Targets - Part 2 of RRMM Podcasts: Practical Insights for the First Relapse · 16 Min. · Folge 48Managing relapsed/refractory multiple myeloma (RRMM), particularly at first relapse, requires timely, evidence-based decisions in an increasingly complex treatment landscape. As…
- Episode 47 - Podcast: First Relapse Sets the Course - Part 1 of RRMM Podcasts: Practical Insights for the First Relapse · 12 Min. · Folge 47Managing relapsed/refractory multiple myeloma (RRMM), particularly at first relapse, requires timely, evidence-based decisions in an increasingly complex treatment landscape. As…
- Episode 46 - What's New Doc? End-of-the-Year Updates on CAR T-cell Therapy in Multiple Myeloma Podcast · 30 Min. · Folge 46CAR T-cell therapies have transformed the management of several previously incurable, treatment-refractory hematologic malignancies, including Multiple Myeloma (MM). With two CAR…
- Episode 45 - Clinical Clips® Crucial Advances in Hemophilia · 19 Min. · Folge 45A number of clinical trials are underway to reduce and prevent bleeding episodes among patients with hemophilia and to improve their overall quality of life by improving joint…
- Episode 44 - Hematologic Cancer Updates | Key Advances in Leukemia, MDS and MF Podcast · 21 Min. · Folge 44Breakthroughs in hematologic cancers continue to emerge. Staying aligned with the newest insights from leading medical conferences is essential for healthcare providers committed…
- Episode 43 - Integrating Emerging Therapies into Clinical Practice for Pediatric ITP: Exploring Evidence, Guidelines and Best Practices · 52 Min.In this podcast, Dr. Cindy Neunert, provides expert insights into emerging data on ITP pathophysiology, diagnosis, and treatment, equipping healthcare providers with the…
- Episode 42 - Talking Hemophilia: Evolving Frontiers in Hemophilia Treatment: Patient-Focused Strategies to Improve Outcomes - Part 4: Patient Perspective in Hemophilia Care · 21 Min.There has been unprecedented research progress in the treatment of hemophilia heralded by the development of non-replacement therapies, emerging factor mimetics, and novel gene…
- Episode 41 - Talking Hemophilia: Evolving Frontiers in Hemophilia Treatment: Patient-Focused Strategies to Improve Outcomes - Part 3: Relevance and Impact of Novel Agents in Hemophilia Care Paradigms · 6 Min.There has been unprecedented research progress in the treatment of hemophilia heralded by the development of non-replacement therapies, emerging factor mimetics, and novel gene…
- Episode 40 - Talking Hemophilia: Evolving Frontiers in Hemophilia Treatment: Patient-Focused Strategies to Improve Outcomes - Part 2: Clinical Evidence on Novel Therapy Options in Hemophilia · 21 Min.There has been unprecedented research progress in the treatment of hemophilia heralded by the development of non-replacement therapies, emerging factor mimetics, and novel gene…
- Episode 39 - Talking Hemophilia: Evolving Frontiers in Hemophilia Treatment: Patient-Focused Strategies to Improve Outcomes - Part 1: Rationale and Potential of Gene Therapy and Rebalancing Agents in Hemophilia · 22 Min.There has been unprecedented research progress in the treatment of hemophilia heralded by the development of non-replacement therapies, emerging factor mimetics, and novel gene…
- Episode 38 - Conversations in IFN-y Driven Diseases: Decoding the Gamma Signal - Part 5: Secondary HLH/MAS & Updates from ASH · 47 Min.Conversations in IFN-y explores the latest advancements in understanding and managing secondary hemophagocytic lymphohistiocytosis (HLH) and macrophage activation syndrome (MAS)…
- Epsiode 37 - What’s New Doc? End of the Year Updates on CAR T-cell Therapy in Multiple Myeloma · 19 Min.What’s New Doc?: CAR T-cells in Multiple Myeloma, highlights key studies and publications from 2024 on the use of these agents in earlier lines of treatment. Dr. Mikhael details…
- Episode 36 - Conversations in IFN-y Driven Diseases: Decoding the Gamma Signal - Part 4: Updates from ACR Convergence 2024 · 47 Min.In this Conversations in IFN-y podcast episode, emerging data from the 2024 ACR meeting is discussed, highlighting advancements in understanding genetic drivers, cytokine…
- Episode 35 - 2024 Highlights and Hindsight in CLL End of Year Updates · 26 Min.In Highlights and Hindsight in CLL, Dr. Matthew Davids will describe the most significant ongoing studies and publications in CLL from 2024 and will detail their impact on the…
- Episode 34 - Clinical Clips in Acute Myeloid Leukemia: Key Updates and Breakthroughs from ASH 2024 · 17 Min.This podcast Clinical Clip features a leading expert highlighting the latest advances in Acute Myeloid Leukemia(AML) treatments presented at the 66th ASH Annual Meeting and…
- Episode 33 - Clinical Clips in Hemophilia: Cutting-Edge Advances Presented at ASH 2024 · 22 Min.Clinical Clips in Hemophilia: Cutting-Edge Advances Presented at ASH 2024, will focus on the most exciting abstracts in hemophilia A and B that would be impactful for improved…
- Episode 32 - Conversations in IFN-y Driven Diseases: Decoding the Gamma Signal - Part 3: Primary HLH · 26 Min.This third podcast episode in the series explores advanced understanding of primary hemophagocytic lymphohistiocytosis (HLH), focusing on its genetic basis, diagnostic…







